Ads
related to: regeneron pharmaceuticals
Search results
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 6 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Zacks via Yahoo Finance· 1 day agoTaking into account individual holdings, Gilead Sciences Inc (GILD) accounts for about 8.31% of the...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoIt trails only Amgen, and now leads Regeneron Pharmaceuticals and Gilead Sciences. The company is...
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Zacks· 1 day agoFree Report) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs? The ...
Health Care Stocks Show Relative Strength as S&P 500 Stalls
Zacks via Yahoo Finance· 2 days agoRegeneron Pharmaceuticals REGN is breaking out of a cup-with-handle base, pushing up against...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks· 6 days agoFree Report) and Regeneron (REGN Quick QuoteREGN - Free Report) announced that the FDA extended the review period for a regulatory filing seeking label expansion for their blockbuster drug Dupixent ...
22 CEOs who founded their Fortune 500 companies
Fortune via Yahoo Finance· 2 days agoHe and his fellow co-founders focused on the buy-side of trading, and integrated investing with risk management. Leonard S. Schleifer Company: Regeneron ...
Intellia’s CRISPR drug shows promise against hereditary angioedema in early-stage trial - Boston...
The Business Journals· 4 days agoBack in 2021, Intellia made history when it successfully edited DNA inside the human body, working...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoProgram Announcement for Annual ASPC Congress on CVD Prevention August 2024 PR Newswire KINGWOOD, Texas, June 4, 2024 Detailed Program Agendas Released for Pre-conference Course and Scientific Sessions KINGWOOD, Texas, June 4, 2024 /PRNewswire/
What's Going On With FibroGen Stock Tuesday? - FibroGen (NASDAQ:FGEN)
Benzinga· 2 days agoFibroGen Inc FGEN shares initially traded higher Tuesday morning after the company said the FDA...
